These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25838542)

  • 1. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
    Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
    Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
    Kouri FM; Ritner C; Stegh AH
    Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
    Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
    Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
    Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
    PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
    Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
    Kumthekar P; Ko CH; Paunesku T; Dixit K; Sonabend AM; Bloch O; Tate M; Schwartz M; Zuckerman L; Lezon R; Lukas RV; Jovanovic B; McCortney K; Colman H; Chen S; Lai B; Antipova O; Deng J; Li L; Tommasini-Ghelfi S; Hurley LA; Unruh D; Sharma NV; Kandpal M; Kouri FM; Davuluri RV; Brat DJ; Muzzio M; Glass M; Vijayakumar V; Heidel J; Giles FJ; Adams AK; James CD; Woloschak GE; Horbinski C; Stegh AH
    Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
    Lan F; Yu H; Hu M; Xia T; Yue X
    J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2.
    Yang L; Wang Y; Li YJ; Zeng CC
    Biomed Pharmacother; 2018 Dec; 108():734-740. PubMed ID: 30248541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-640 Inhibition Enhances the Chemosensitivity of Human Glioblastoma Cells to Temozolomide by Targeting Bcl2 Modifying Factor.
    Jiang S; Luo C; Chen Y; Chen J; Tao S; Zou Q; He C; Dong S
    Biochem Genet; 2023 Apr; 61(2):538-550. PubMed ID: 35984538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
    El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
    Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
    Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
    Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
    Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
    Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.